LORRIE NORMAN: Open Payments
NPI 1346975810 · ENGLEWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 26 payments from 7 companies in 2025. Trend: 2023 $575 · 2024 $617 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $156 |
| Lilly USA, LLC | 6 | $146 |
| Amgen Inc. | 7 | $110 |
| Novo Nordisk Inc | 5 | $88 |
| Boston Scientific Corporation | 1 | $22 |
| Organon LLC | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: AIRSUPRA, ZEPBOUND, Ozempic, OTEZLA, EVENITY, REPATHA, MOUNJARO, WATCHMAN FLX.
Industry payments across FL — which companies pay providers there.
